Use of Marrow Scintigraphy to Confirm Compensatory Marrow Rather than Active Myeloma.

Authors

Twyla B Bartel
Tracy L. Yarbrough, George Washington University
Lorraine E De Blanche

Document Type

Journal Article

Publication Date

9-1-2016

Journal

World Journal of Nuclear Medicine

Volume

15

Issue

3

Inclusive Pages

203-205

DOI

10.4103/1450-1147.172303

Abstract

We present the case of a 40-year-old male with multiple myeloma for whom bone marrow scintigraphy was utilized to help differentiate between active bony myelomatous disease versus treated lesions with compensatory marrow uptake. This case demonstrates technetium (Tc-99m) sulfur colloid imaging as an inexpensive technique to quickly distinguish between active focal bone disease and reactive marrow.

Comments

Reproduced with permission of Wolters Kluwer. World Journal of Nuclear Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.

APA Citation

Bartel, T., Yarbrough, T. L., & De Blanche, L. (2016). Use of Marrow Scintigraphy to Confirm Compensatory Marrow Rather than Active Myeloma.. World Journal of Nuclear Medicine, 15 (3). http://dx.doi.org/10.4103/1450-1147.172303

Peer Reviewed

1

Open Access

1